Patent · US Active

Inhibitor compounds of phosphodiesterase type 10A

US9790203B2 · kind B2 · utility

1Cited by

0References

26Claims

0Family size

Assignees

Abb Vie Inc. · US
Abb Vie Deutschland Gmbh & Co. KG · DE

Inventors

Hervé Geneste · Schifferstadt, DE
Sean Colm Turner · Ludwigshafen, DE
Michael Ochse · Wiesbaden, DE
Karla Drescher · Ludwigshafen, DE
Lawrence A. Black · Libertyville, US
Katja Jantos · Ludwigshafen, DE

Key dates

Filing date	Nov 22, 2013
Grant date	Oct 17, 2017
Priority date	—
Expiry date	Nov 22, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds which are inhibitors of phosphodiesterase type 10A and to their use for the manufacture of a medicament and which thus are suitable for treating or controlling of medical disorders selected from neurological disorders and psychiatric disorders, for ameliorating the symptoms associated with such disorders and for reducing the risk of such disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.